Source link : https://newshealth.biz/health-news/tiragolumab-disappoints-in-untreated-advanced-hcc/
Targeting TIGIT with tiragolumab does not improve outcomes over atezolizumab plus bevacizumab in untreated advanced hepatocellular carcinoma, shows a trial that questions the future of the approach. Medscape Medical News Source link : https://www.medscape.com/viewarticle/tiragolumab-disappoints-untreated-advanced-hcc-2025a1000svv?src=rss Author : Publish date : 2025-10-23 13:44:00 Copyright for syndicated content belongs to the linked Source.
The post Tiragolumab Disappoints in Untreated Advanced HCC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-23 13:44:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8